Integra LifeSciences (NASDAQ:IART – Get Free Report) and Nanovibronix (NASDAQ:FEED – Get Free Report) are both small-cap healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, earnings, dividends, risk, valuation, institutional ownership and analyst recommendations.
Profitability
This table compares Integra LifeSciences and Nanovibronix’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Integra LifeSciences | 0.79% | 18.63% | 5.49% |
| Nanovibronix | -1,093.61% | -60.73% | -48.48% |
Risk and Volatility
Integra LifeSciences has a beta of 1.21, suggesting that its stock price is 21% more volatile than the S&P 500. Comparatively, Nanovibronix has a beta of 1.46, suggesting that its stock price is 46% more volatile than the S&P 500.
Analyst Recommendations
This is a breakdown of current ratings and price targets for Integra LifeSciences and Nanovibronix, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Integra LifeSciences | 3 | 5 | 2 | 0 | 1.90 |
| Nanovibronix | 1 | 0 | 0 | 0 | 1.00 |
Integra LifeSciences presently has a consensus price target of $16.12, indicating a potential upside of 26.47%. Given Integra LifeSciences’ stronger consensus rating and higher probable upside, analysts clearly believe Integra LifeSciences is more favorable than Nanovibronix.
Institutional and Insider Ownership
84.8% of Integra LifeSciences shares are owned by institutional investors. Comparatively, 16.4% of Nanovibronix shares are owned by institutional investors. 3.8% of Integra LifeSciences shares are owned by insiders. Comparatively, 12.2% of Nanovibronix shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
Earnings & Valuation
This table compares Integra LifeSciences and Nanovibronix”s revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Integra LifeSciences | $1.66 billion | 0.60 | -$516.47 million | $0.17 | 75.00 |
| Nanovibronix | $1.93 million | 0.11 | -$18.18 million | ($117.28) | -0.00 |
Nanovibronix has lower revenue, but higher earnings than Integra LifeSciences. Nanovibronix is trading at a lower price-to-earnings ratio than Integra LifeSciences, indicating that it is currently the more affordable of the two stocks.
Summary
Integra LifeSciences beats Nanovibronix on 11 of the 14 factors compared between the two stocks.
About Integra LifeSciences
Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services. It also sells instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute wounds; and surgical tissue repair products for hernia, tendon, peripheral nerve repair and protection. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.
About Nanovibronix
NanoVibronix Inc. is a medical device company that is focused on creating medical products utilizing its proprietary low-intensity, surface acoustic wave technology. … NanoVibronix’ catheter-based products include the UroShield™ and NG-Shield™ devices that are both CE mark certified.
Receive News & Ratings for Integra LifeSciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integra LifeSciences and related companies with MarketBeat.com's FREE daily email newsletter.
